DK25093A - Mellemprodukter til fremstilling af terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser - Google Patents

Mellemprodukter til fremstilling af terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser

Info

Publication number
DK25093A
DK25093A DK025093A DK25093A DK25093A DK 25093 A DK25093 A DK 25093A DK 025093 A DK025093 A DK 025093A DK 25093 A DK25093 A DK 25093A DK 25093 A DK25093 A DK 25093A
Authority
DK
Denmark
Prior art keywords
ribofuranosylselenazole
intermediates
beta
preparation
therapeutic active
Prior art date
Application number
DK025093A
Other languages
English (en)
Other versions
DK25093D0 (da
DK172165B1 (da
Inventor
Roland Kenith Robins
Pram Chandra Srivastava
Original Assignee
Univ Brigham Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brigham Young filed Critical Univ Brigham Young
Publication of DK25093D0 publication Critical patent/DK25093D0/da
Publication of DK25093A publication Critical patent/DK25093A/da
Application granted granted Critical
Publication of DK172165B1 publication Critical patent/DK172165B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D421/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D421/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
    • C07D421/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK025093A 1982-03-23 1993-03-08 Mellemprodukter til fremstilling af terapeutisk aktive 2-beta-D-ribofuranosylselenazol-4-carboxamidforbindelser DK172165B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36096882A 1982-03-23 1982-03-23
US36096882 1982-03-23
US06/465,221 US4531001A (en) 1982-03-23 1983-02-15 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
US46522183 1983-02-15

Publications (3)

Publication Number Publication Date
DK25093D0 DK25093D0 (da) 1993-03-08
DK25093A true DK25093A (da) 1993-03-08
DK172165B1 DK172165B1 (da) 1997-12-08

Family

ID=27001098

Family Applications (2)

Application Number Title Priority Date Filing Date
DK129983A DK167765B1 (da) 1982-03-23 1983-03-22 Analogifremgangsmaade til fremstilling af 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser
DK025093A DK172165B1 (da) 1982-03-23 1993-03-08 Mellemprodukter til fremstilling af terapeutisk aktive 2-beta-D-ribofuranosylselenazol-4-carboxamidforbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK129983A DK167765B1 (da) 1982-03-23 1983-03-22 Analogifremgangsmaade til fremstilling af 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser

Country Status (14)

Country Link
US (1) US4531001A (da)
EP (1) EP0089678B1 (da)
KR (1) KR880001869B1 (da)
AU (1) AU553665B2 (da)
CA (1) CA1209986A (da)
DE (1) DE3366378D1 (da)
DK (2) DK167765B1 (da)
ES (5) ES8404373A1 (da)
FI (1) FI76574C (da)
GR (1) GR78301B (da)
IE (1) IE54520B1 (da)
NO (1) NO155842C (da)
NZ (1) NZ203649A (da)
PT (1) PT76426B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619996A (en) * 1984-07-09 1986-10-28 Warner-Lambert Company Process for preparing 2-β-D-ribofuranosylselenazole-4-carboxamide
US4801698A (en) * 1986-08-15 1989-01-31 Warner-Lambert Company Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide
US5438131A (en) * 1992-09-16 1995-08-01 Bergstrom; Donald E. 3-nitropyrrole nucleoside
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
WO1996026212A1 (en) * 1995-02-17 1996-08-29 Icn Pharmaceuticals, Inc. Procedures for obtaining ribo-c-nucleosides
SI20161A (sl) * 1997-06-30 2000-08-31 Icn Pharmaceuticals, Inc. Postopek za proizvodnjo tiazofurina in drugih C-nukleozidov

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423399A (en) * 1966-06-09 1969-01-21 Takeda Chemical Industries Ltd Method for the production of 5'-ribonucleotide
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters

Also Published As

Publication number Publication date
IE830580L (en) 1983-09-23
CA1209986A (en) 1986-08-19
EP0089678B1 (en) 1986-09-24
ES520826A0 (es) 1984-05-01
DK25093D0 (da) 1993-03-08
DK167765B1 (da) 1993-12-13
EP0089678A1 (en) 1983-09-28
NO831012L (no) 1983-09-26
FI830941A0 (fi) 1983-03-22
DK129983D0 (da) 1983-03-22
NZ203649A (en) 1985-02-28
ES8600322A1 (es) 1985-10-01
PT76426B (en) 1986-02-04
ES8600323A1 (es) 1985-10-01
AU553665B2 (en) 1986-07-24
FI76574B (fi) 1988-07-29
KR840004126A (ko) 1984-10-06
FI76574C (fi) 1988-11-10
NO155842B (no) 1987-03-02
FI830941L (fi) 1983-09-24
AU1269383A (en) 1983-09-29
DE3366378D1 (en) 1986-10-30
ES527279A0 (es) 1985-10-01
NO155842C (no) 1987-06-10
ES8404373A1 (es) 1984-05-01
KR880001869B1 (ko) 1988-09-23
ES527276A0 (es) 1985-10-01
DK129983A (da) 1983-09-24
DK172165B1 (da) 1997-12-08
IE54520B1 (en) 1989-11-08
PT76426A (en) 1983-04-01
ES8600321A1 (es) 1985-10-01
ES8504795A1 (es) 1985-04-16
US4531001A (en) 1985-07-23
GR78301B (da) 1984-09-26
ES527278A0 (es) 1985-04-16
ES527277A0 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
DK166280C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive 2-azetidinoner
DK157063C (da) Fremgangsmaade til fremstilling af unilamellaere liposomer
DK1183A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK158820C (da) Fremgangsmaade til fremstilling af vandingsroer
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK435082A (da) Fremgangsmaade til fremstilling af benzamider
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK427281A (da) Fremgangsmaade til fremstilling af terapeutiske praeparater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK25093A (da) Mellemprodukter til fremstilling af terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser
DK340483A (da) Fremgangsmaade til fremstilling af fluoralkylerede carbapenemderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK507282A (da) Fremgangsmaade til fremstilling af azinorifamycin forbindelser
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK273183D0 (da) Fremgangsmade til fremstilling af amidiner
DK126181A (da) Fremgangsmaade til fremstilling af bicyclooctanforbindelser
DK519183D0 (da) Fremgangsmade til fremstilling af oxazolinoazetidinon-forbindelser
DK62283D0 (da) Fremgangsmade til fremstilling af peptidergotalkaloider
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK285683A (da) Fremgangsmaade til fremstilling af substituerede phenylpiperazinforbindelser
DK287083D0 (da) Fremgangsmade til fremstilling af polyenforbindelser
DK10883D0 (da) Fremgangsmade til fremstilling af substituerede chloracetanilider

Legal Events

Date Code Title Description
A0 Application filed
B1 Patent granted (law 1993)
PUP Patent expired